Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
10/2003
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353894A2 Synthesis of ketosulfone esters
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003CN1451013A Nucleophile-stable thoester generating compounds, method of production and use
10/22/2003CN1450054A Purifying process for 5-(2-ethyl thio propyl)-1,3-cyclohexanedione
10/22/2003CN1450047A Process for preparation of cyclic diketones
10/22/2003CN1125061C C2 taxane derivatives and pharmaceutical compositions containing them
10/22/2003CN1125060C C-10 taxane derivatives and pharmaceutical compositions containing them
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635318 Very high specific resistance values; low threshold voltages; for MLC (matrix),TN (Schadt-Helfrick) or STN (supertwisted) displays, particularly for reflective MLC; high clearing point, low rotational viscosity and low birefringence
10/21/2003CA2115277C Cyclohexenone oxime ethers
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084982A2 Functionalized compositions for improved immobilization
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084924A2 Electron donors, electron acceptors and adhesion promoters containing disulfide
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084912A1 3-keto or 3-oximoether substituted benzoylcyclohexanediones
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002100339A3 Novel process for preparing rac-bicalutamide and its intermediates
10/16/2003WO2002092024A3 Compounds and methods for inhibiting axillary malodour
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003WO2002038539A3 A method of making a calcium salt of 2-hydroxy-4-(mercaptomethyl)butanoic acid
10/16/2003US20030195363 Reacting 2,5-disubstituted-phenylalkylsulfide compound with halogenating agent to produce 2,5-disubstituted-phenylsulfenylhalide compound
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195357 Ruthenium complexes containing carboids
10/16/2003US20030195354 For use as fungicide
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195159 HIV protease inhibitors based on amino acid derivatives
10/16/2003US20030194417 Cysteine derivatives
10/16/2003CA2481808A1 3-keto-or 3-oxime-ether-substituted benzoylcyclohexanediones
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2464144A1 Functionalized compositions for improved immobilization
10/15/2003EP1353225A2 Radiation sensitive composition and compound
10/15/2003EP1352901A2 Process for the preparation of cyclic diketones
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351913A2 1,4-diaryl-2,3-difluoro-2-butene insecticidal and acaricidal agents
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP0916651B1 Phenylalkylcarboxylic acid derivatives
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124259C Benzylsulfide derivative, process for its production and pesticide
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632826 Carbocyclic HIV protease inhibitors
10/14/2003US6632484 1,3-dioxane and/or cyclohexane derivatives; low positive or negative value of the dielectric anisotropy and can be used in liquid-crystal and electro-optical display elements
10/14/2003CA2142410C Nitro-substituted polymeric corrosion inhibition for aluminum flake pigment
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191270 Electron donors, electron acceptors and adhesion promoters containing disulfide
10/09/2003US20030191217 Amorphous or liquid phenolic compounds having a carboxy group as stabilizers for processing molding plastics are controllably, uniformly dispersed and reproducible; nondiffusing; no bleeding-out; no surface deposits
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030189808 Bis(4-mercaptophenyl)sulfide derivatives, process for the preparation thereof and electronic components
10/09/2003CA2480857A1 Improvements in pharmaceutical compositions
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/08/2003EP1140761B1 Benzophenones and the use thereof as photoinitiators
10/08/2003CN1447815A Ruthenium complexes contg. carboids
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123581C Fluorinated ion-exchange polymers and intermediates therefor
10/08/2003CN1123564C Anti-inflammatory compounds
10/08/2003CN1123339C Diabetes remedies
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/07/2003US6630540 Covulcanizable anti-aging agents
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630509 Phenalkyloxy-phenyl derivatives
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/02/2003WO2003080631A2 Plasma carboxypeptidase b inhibitors
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003080041A1 Remedies for arthritis deformans
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2002033596A3 Method of operating a computer system to perform a discrete substructural analysis
10/02/2003US20030187279 Process for the production of r(+) alpha-lipoic acid
10/02/2003US20030187235 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
10/02/2003US20030187041 Cardiovascular disorders
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003US20030185778 Polyamine compounds and compositions for use in conjunction with cancer therapy
10/02/2003CA2714873A1 Plasma carboxypeptidase b inhibitors
10/01/2003EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003EP1044965B1 Process for the preparation of aromatic sulfur compounds
10/01/2003EP0873290B1 Process for racemization of n-acetyl-d(l)-alpha-aminocarboxylic acids
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446196A Acylacetonitriles, process for preparation thereof and miticides containing the same
10/01/2003CN1445214A Amphiprotic compound containing sulphur, its preparing method and usage
10/01/2003CN1122657C Colchicine skeleton compounds, their use as medicaments and compounds containing them
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 272